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Background: Hip fractures result in both health and cost burdens from a public health perspective and have a
major impact on the health care system in the USA. The purpose was to examine whether there were systematic
differences in hip fracture incidence and 30-, 90-, and 365-day mortality after hip fracture in the California
population as a function of age, gender, and race/ethnicity from 2000–2011.
Methods: This was a population-based study from 2000 to 2011 using data from the California Office of Statewide
Health and Planning and Development (OSHPD, N = 317,677), California State Death Statistical Master File records
(N = 224,899), and the US Census 2000 and 2010. There were a total of 317,677 hospital admissions for hip fractures
over the 12-year span and 24,899 deaths following hip fractures. All participants without linkage (substituted for
social security) numbers were excluded from mortality rate calculations. Variation in incidence and mortality rates
across time, gender, race/ethnicity, and age were assessed using Poisson regression models. Odds ratio and 95 %
confidence intervals are provided.
Results: The incidence rate of hip fractures decreased between 2000 and 2011 (odds ratio (OR) = 0.98, 95 %
confidence interval (CI) 0.98, 0.98). Mortality rates also decreased over time. There were gender, race/ethnicity, and
age group differences in both incidence and mortality rates.
Conclusions: Males were half as likely to sustain a hip fracture, but their mortality within a year of the procedure is
almost twice the rate than women. As age increased, the prevalence of hip fracture increased dramatically, but
mortality did not increase as steeply. Caucasians were more likely to sustain a hip fracture and to die within 1 year
after a hip fracture. The disparities in subpopulations will allow for targeted population interventions and
opportunities for further research.
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Hip fractures have a major impact on the health care
system in the USA with an estimated incidence of
340,000 fractures annually [1]. The annual economic
burden of managing hip fractures was estimated at $17–
20 billion in 2010 [1, 2]. As people are expected to live
longer, hip fractures will become more common. It is
estimated that by the year 2050 worldwide, there will be
an estimated 6.3 million hip fractures worldwide [3]. Hip* Correspondence: wtimbrox@gmail.com
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older person. Often after an initial hip fracture, a person
cannot continue living independently and must undergo
drastic lifestyle changes [4, 5]. In addition, there is an
association between hip fractures and an increase in
mortality. One year mortality rate after a hip fracture is
estimated between 17 and 27 % [6–9].
The study has two primary hypotheses: first, that there
are population factor variations in hip fracture incidence
and, second, that there are systematic variations in
mortality after hip fracture within the California popula-
tion. A secondary hypothesis is that there has been a
change in incidence trends over time from 2000 to 2011.e is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Sullivan et al. Journal of Orthopaedic Surgery and Research  (2016) 11:4 Page 2 of 10Several factors may be associated with hip fracture in-
cidence such as age, gender, and race/ethnicity [1, 10].
California is a diverse state and provides an opportunity
to examine these factors in relation to incidence of hip
fracture and mortality following a hip fracture. The goal
was to explore the effects of gender, age, and race/
ethnicity, with regard to the incidence of hip fracture
and 30-, 90-, and 365-day mortality rates in California
from 2000 to 2009.
In the recent era of increasing health care quality
measurement, these population data and analysis will be
helpful in the interpretation of patient hip fracture inci-
dence and mortality outcomes [11].
Methods
This study was a population-based epidemiological re-
view of all California Office of Statewide Health andFig. 1 Flow diagram to show the creation of the study sample for the inciPlanning and Development (OSHPD) non-federal hos-
pital admissions for hip fractures from 2000 to 2011.
Mortality data was extracted from the California State
Death Statistical Master File (DSMF) records. Par-
ticipants were assigned a linkage number, similar to a
de-identified social security number, and data from ini-
tial hospital admission OSHPD records were linked to
DSMF records, if applicable (e.g., if death had occurred).
This linking method has previously been explained in
detail [12].
Participants were any patient 55 years and older ad-
mitted with the primary International Classification of
Disease, 9th Revision (ICD-9) procedure code for the
treatment of hip fractures. These include partial hip
arthroplasty (ICD9 81.52), internal fixation of bone with-
out fracture reduction (ICD-9 78.55), closed reduction
of fracture with internal fixation (ICD-9 79.15), opendence of hip fractures
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(ICD-9 79.35), and open reduction of separated
epiphysis (ICD-9 79.55); see comments in study limi-
tation section with regard to (ICD-9 79.55). There
were a total of 317,677 hospital admissions for hip
fractures over the 12-year span and 24,899 deaths fol-
lowing hip fractures (Figs. 1 and 2). All participants
without linkage (substituted for social security) num-
bers were excluded from mortality rate calculations.
To evaluate the differences in the incidence of hip
fracture, the outcome variable was incidence rate. ToFig. 2 Flow diagram to show the creation of the study sample for mortalitevaluate the difference in mortality, the outcome vari-
ables were 30-, 90-, and 365-day mortality. Hip fracture
incidence rates were calculated based on hospital admis-
sion; a patient with multiple hip fractures could be
counted twice toward hip fracture incidence rates.
Both incidences of hip fracture and mortality were
evaluated by gender, age, race/ethnicity, and geo-
graphical area. Gender had two levels, male and female.
Females were used as a reference group. Age was cate-
gorized in seven levels: 55–59, 60–64, 65–69, 70–74,
75–79, 80–84, and 85+. The 65–69 age group was usedy after hip fractures
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is eligible for Medicare. Race/ethnicity had six levels:
Caucasian, African American, Hispanic, Asian, Native
American, and other. Caucasians were used as a refer-
ence group because they were the largest racial/ethnic
subgroup (Table 1).
Rates were calculated by first calculating the count of
hip fracture incidence in a relevant category. All analyses
were weighted based on California population statistics,
as described by the 2000 and 2010 US Census reports
[13, 14]. For all years between 2000 and 2010, census
distributions were interpolated. In addition, all age rates
were weighted by the proportion of each relevant age
group in the population. This prevented rates from
being inflated by high rates in groups with low absolute
counts (e.g., the oldest age groups). Differences in the in-
cidence and mortality rate of hip fractures, based on
various subgroups, were evaluated using Poisson regres-
sion models. Odds ratios (OR) are provided with 95 %
confidence intervals (CI). All analyses were conducted in
SPSS version 22 (Armonk, NY), Microsoft Excel
(Redmond, WA), and R (Vienna, Austria).
Missing data were minimal for all analyses; cases with
missing data were excluded from relevant analyses. Less
than 3 % of the sample were missing a social security
number and had to be excluded from death rate calcula-
tions. All participants without gender information were
excluded as all analyses were split by gender. All partici-
pants with gender information also had age information.Table 1 Demographics
Demographic variable N (%)
Gender
• Female 229,212 (72)
• Male 88,465 (28)
Age
• 55–59 11,367 (3.6)
• 60–64 14,329 (4.5)
• 65–69 18,907 (6.0)
•70–74 28,717 (9.0)
• 75–79 48,269 (15.2)
• 80–84 70,353 (22.1)
• 85+ 125,735 (39.6)
Race/ethnicity
• Caucasian 250,407 (78.8)
• Hispanic 31,154 (9.8)
• African American 8818 (2.8)
• Native American 473 (0.1)
• Asian 16,811 (5.3)
• Other 4900 (1.5)In addition, 1.6 % of people had missing race/ethnicity
data and were excluded from those analyses.Results
Hip fracture incidence
All results were weighted using population rates from
the US Census Bureau [13, 14] and are presented in
Table 2. Hip fracture rates decreased over time (OR
0.98, 95 % CI 0.98, 0.98, p < .001, Fig. 3). Males were
found to have a lower incidence of hip fractures than
females (OR 0.46, 95 % CI 0.46, 0.47, p < .001, Fig. 3). As
gender differences were dramatic, all subsequent ana-
lyses were performed on males and females separately.
As a person ages, they are more likely to sustain a hip
fracture; females 85 years and above were 18.73 times
more likely to sustain a hip fracture than those aged 65–
69 (95 % CI 18.36, 19.10, p < .001). The relationship in
males was even more dramatic, those 85 and above
were 32.79 times more likely to sustain a hip frac-
ture than the reference group (95 % CI 32.15, 33.43,
p < .001; (Figs. 4 and 5). Caucasians had the highest
incidence of hip fracture across all race/ethnicity
groups; Native Americans had the lowest rates in
reference to Caucasians (females OR 0.26, 95 % CI
0.24, 0.29, p < .001; males OR, 0.26, 95 % CI 0.21,
0.30, p < .001, Figs. 6 and 7).Table 2 Adjusted odds ratio and 95 % confidence intervals
(95 % CI) of gender, age group, and race/ethnicity in hip
fracture patients from 2000–2011
Variable
Year 0.98 [0.98, 0.98]a
Female Male
Gender 1.00 0.46 [0.98, 0.98]a
Age group (years)
55–59 0.64 [0.61, 0.66]a 0.66 [0.64, 0.69]a
60–64 0.61 [0.60, 0.62]a 0.66 [0.64, 0.69]a
65–69 1.00 1.00
70–74 1.92 [1.88, 1.95]a 1.92 [1.84, 1.99]a
74–79 4.06 [3.98, 4.14]a 4.62 [4.53, 4.71]a
80–84 10.70 [10.49, 10.91]a 12.18 [11.95, 12.42]a
85+ 18.73 [18.36, 19.10]a 32.79 [32.15, 33.43]a
Race/ethnicity
Caucasian 1.00 1.00
Asian 0.32 [0.32, 0.33]a 0.32 [0.30, 0.33]a
African American 0.35 [0.35, 0.36]a 0.49 [0.47, 0.51]a
Hispanic 0.39 [0.39, 0.40]a 0.48 [0.0, 0.04]a
Native American 0.26 [0.24, 0.29]a 0.25 [0.21, 0.30]a
ap < 0.001
Fig. 3 Hip fracture incidence rates over time
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All results were weighted using population rates
from the US Census Bureau [13, 14]. Thirty, 90 and
365 day mortality results presented in Table 3. Over
time, mortality rates decreased in both genders at
30-day post procedure (OR 0.97, 95 % CI 0.96, 0.98,
p < .001, Fig. 6), 90-day post procedure (OR 0.97, 95 %
CI 0.96, 0.98, p < .001), and 365-day post procedure (OR
0.98, 95 % CI 0.98, 0.98, p < .001, Fig. 6). Males were
nearly two times more likely to die within 30 days of
a procedure than females (OR 1.79, 95 % CI 1.72,
1.86, p < .001) and were more likely to die at all
assessed time points. Across all time mortality rate
assessments, there were no differences in mortality
rates for males between age groups 55–59, 60–64,
and 64–69; however, females aged 55–59 had lower
mortality rates than those aged 64–69 (OR 0.73, 95 %
CI 0.55, 0.98, p < .05). For both genders, beyond age
69, risk of death increased as a person aged. For both
genders, Caucasians were more likely to die at 30, 90,Fig. 4 Female hip fracture incidence rates over time, by age groupand 365 days than all other races. Asians had the
lowest mortality rates as compared to Caucasians (fe-
male, 30-day OR 0.59, 95 % CI 0.51, 0.68, p < .001;
male, 30-day OR, 0.62, 95 % CI 0.52, 0.74, p < .001).
Discussion
Discussion of hip fracture incidence
There are multiple individual risks for the occurrence of
a hip fracture including but not limited to osteoporosis,
smoking, general health status, medical co-morbidities,
exercise, and socio-economic status [1, 15]. In this study,
we found that Caucasian females, aged 85+ were at the
most risk for a hip fracture. Figure 3 (procedure rates
over time) graphically illustrates the significant dif-
ference in hip fracture incidence with men having an in-
cidence about half that of women. This study reports
results consistent with similar studies done with
Medicare data, European population studies, and previ-
ous studies on California data[1, 4, 16, 17]. When evalu-
ating programs designed to reduce the incidence of hip
Fig. 5 Male hip fracture incidence rates over time, by age group
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any program evaluation [16].
Figures 4 (female hip fracture rates over time) and 5
(male hip fracture rates over time) graphically illustrates
that hip fracture incidence for men and women over the
age of 70 declined over the study time period. These de-
clines are an extension of the trend noted by Brauer
et al. [1]. They suggest an improved trend for the overall
California population in line with the Swiss population
[18]. This improved trend may be partially explained by
widespread prescription of bisphosphonate medications
but improved population health, decreasing incidence of
tobacco use and public health promotion of increased
activity and healthy lifestyles are also possible contri-
butors to this trend [9, 19, 20]. Kannus et al. [21] in
agreement with this statement speculate that the bio-
logical basis for this declining rate is multifactorial.Fig. 6 Female hip fracture incidence rates over time, by race/ethnicityFigures 6 (female hip fracture rates over time, by race/
ethnicity) and 7 (male hip fracture rates over time, by
race/ethnicity) graphically illustrate that white men and
women have a significantly higher incidence of hip frac-
tures compared to the remainder of the population. The
decline in incidence rate over the study time period has
been more significant for white men and women.
Figure 6 (female hip fracture rates over time, by race/
ethnicity) is an interesting and consistent extension of
Fig. 1a published in Zingmond et al. [8] for the period
1983–1998. The ethnic disparities are consistent with
the data of Silverman and Madison from 1983–1984 [5].
When compared to Kanis et al., the data of the white
population has an incidence rate similar to Sweden,
Norway, Austria, and Ireland [22]. The remainder of the
population has an incidence rate consistent with Spain,
Mexico, and Chile, which are similar to a review done
Fig. 7 Male hip fracture incidence rates over time, by race/ethnicity
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population found in a similar time period that incidence
of Hispanic hip fractures had not declined, similar to
our study [2]. Investigations of the race/ethnicity factor
for hip fractures has been further confused by the chan-
ging demographics of the US population.
Discussion of hip fracture mortality
There are multiple individual risks for the occurrence
of mortality following a hip fracture including butTable 3 Adjusted odds ratio and 95 % confidence intervals (95 % C
patients from 2000–2009
30-day mortality 90-day m
Variable
Year 0.97 [0.96, 0.98]a 0.97 [0.9
Female Male Female
Gender 1.00 1.79 [1.72, 1.86]a 1.00
Age group (years)
55–59 0.73 [0.55, 0.98]c 0.79 [0.60, 1.03] 0.84 [0.6
60–64 0.87 [0.67, 1.21] 0.95 [0.74, 1.23] 0.89 [0.7
65–69 1.00 1.00 1.00
70–74 1.18 [0.97, 1.44] 1.60 [1.29, 1.98]a 1.20 [1.0
75–79 1.49 [1.25, 1.78]a 2.20 [1.81, 2.68]a 1.43 [1.2
80–84 1.73 [1.48, 2.02]a 2.61 [2.18, 3.11]a 1.80 [1.5
85+ 3.25 [2.78, 3.81]a 4.22 [3.54, 5.03]a 3.32 [2.9
Race/ethnicity
Caucasian 1.00 1.00 1.00
Asian 0.59 [0.51, 0.68]a 0.62 [0.52, 0.74]a 0.52 [0.4
African American 0.78 [0.67, 0.91]c 0.64 [0.53, 0.78]a 0.78 [0.6
Hispanic 0.79 [0.71, 0.87]a 0.68 [0.61, 0.77]a 0.71 [0.6
ap < 0.001; bp < 0.01; cp < 0.05not limited to body pre-operative functional status,
pre-operative cognitive status, congestive heart failure,
general health status, diabetes, other medical co-
morbidities, and occurrence of post-operative patient
complications (notably sepsis) [24, 25]. In this study,
we found that Caucasian males aged 85+ was the
profile for patients at the most risk for a hip fracture
mortality. That males were more likely than their
female counterparts to die following a hip fracture
was particularly interesting because females had theI) of gender, age group, and race/ethnicity in hip fracture
ortality 365-day mortality
6, 0.98]a 0.98 [0.98, 0.98]a
Male Female Male
1.63 [1.57, 1.70]a 1.00 1.43 [1.41, 1.46]a
7, 1.04] 0.70 [0.56, 0.89]b 0.96 [0.81, 1.15] 0.74 [0.61, 0.90]b
3, 1.08] 0.98 [0.81, 1.19] 0.99 [0.85, 1.16] 0.99 [0.83, 1.18]
1.00 1.00 1.00
2, 1.40]c 1.45 [1.21, 1.72]a 1.30 [1.15, 1.46]a 1.39 [1.21, 1.60]a
5, 1.64]a 1.99 [1.70, 2.33]a 1.54 [1.37, 1.73]a 1.86 [1.62, 2.13]a
7, 2.07]a 2.41 [2.10, 2.77]a 1.95 [1.74, 2.20]a 2.32 [2.06, 2.61]a
5, 3.73]a 3.71 [3.23, 4.25]a 3.56 [3.23, 3.93]a 3.42 [3.04, 3.85]a
1.00 1.00 1.00
6, 0.58]a 0.59 [0.51, 0.68]a 0.51 [0.46, 0.56]a 0.57 [0.51, 0.64]a
8, 0.89]a 0.66 [0.56, 0.79]a 0.73 [0.65, 0.82]a 0.73 [0.63, 0.83]a
6, 0.77]a 0.66 [0.60, 0.72]a 0.66 [0.63, 0.70]a 0.65 [0.60, 0.70]a
Fig. 8 30-, 90-, and 365-day mortality rates over time
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mortality risk associated with increasing age and male
gender has been widely noted in other studies of this
topic [7, 26–28].
Figure 8 (30-, 90-, and 365-day mortality rates over
time) graphically illustrates that all mortality rates
decreased over the study time period. This is a re-
sumption of a trend to decreased mortality that
Brauer et al. noted had stalled in about 1998 [1].
Figures 9 and 10 graphically illustrate that the inci-
dence of 30-day mortality varies by decade of life for
both men and women. These gender- and age-specific
baseline mortality rates will be helpful to risk adjust
the incidence of mortality after hip fracture care.
Mortality rates are being introduced in the USA and
elsewhere as a quality measure for hip fracture care
[11]. There has been an increase in the use of sys-
tematic interventions including co-operative care be-
tween surgeons and medical practitioners, attentionFig. 9 Female 30-day mortality rates over time, by ageto pain management, delirium prevention, early sur-
gery, and aggressive mobilization [29–32].
Penrod et al. in a study of approximately 3000 pa-
tients from 1997–1999 found that white patients
enjoyed a mortality risk advantage compared to the
rest of the study population [25]. Our study was
based on a much larger and more comprehensive
study population. Sterling documented a gap in the
literature with regard to racial and ethnic differences
in the survival of US hip fracture patients [33]. A
more current literature search has failed to find
current studies on this topic. One older citation was
based on a very different racial/ethnic population
compared to 2009 [3].
Limitations
One limitation was that we selected our dataset based
on the principal procedure code only. Other procedure
codes are recorded, and so there is a possibility that we
Fig. 10 Male 30-day mortality rates over time, by age
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not coded as their principal procedure. This is ICD-9
data and laterality is not a data element.
Although the patient data record contains information
regarding the hospital where the surgery occurred, there
is no data with regard to transfers of patients for admis-
sion, subsequent re-operations at a second hospital for
the same fracture, nor data with regard to the individual
attending surgeon. These factors would all be useful
information for the analysis [34, 35].
Another limitation is the inadvertent inclusion of a
small group of patients (n = 296) who had a principal
procedure code of 79.55 (open reduction of separated
epiphysis, femur) and were older than age 55. Since this
is a pediatric orthopedic procedure, this combination of
principal procedure code and age is likely the result of
incorrect coding at the hospital level. However, it is
unknown if the incorrect coding was in the age of the
patient or the principal procedure code. The number of
patients is small (0.09 %), data analysis was not re-done,
and inclusion of this subset should not significantly
affect the results.
The last important limitation of using the OSHPD
dataset was the lack of important clinical risk data
(e.g., smoking status, substance abuse status, socio-
economic status information, opioid use, pre-operative
mobility, and cognitive status, etc.) [1, 15]. Due to the
nature of the dataset, there was no way to analyze
any of these factors and therefore we must accept this
limitation of applying these results to health effective-
ness research.
Conclusion
This California state-wide population-based study of a
large and diverse population shows a significantreduction in hip fracture incidence over the study period
of 2000–2011 and a corresponding reduction in mortal-
ity over the study period of 2000–2009. There are sig-
nificant gender, age, race/ethnicity disparities for both
hip fracture incidence and mortality in subpopulations
that will allow for targeted population interventions and
opportunities for further research. Further, these data
will provide baseline information to assess and risk strat-
ify outcomes and interventions.
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